Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline
Status:
Withdrawn
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This is a single-center, randomized, open-label, single- and multiple-dose, five-treatment,
two-period, four-way parallel study comparing the pharmacokinetics (PK) of Diazoxide Choline
Controlled-Release Tablet (DCCR) administered orally under fed and fasting conditions at two
dose levels.